E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI)
Doctors and researchers across the United States have been working to understand a new series of illnesses known as EVALI, e-cigarette or vaping product use-associated lung injury; searching for the answer to the growing question, “what is the cause of vaping lung?“. The lung injury, previously known as VAPI (vaping associated pulmonary illness), describes a number of related severe lung illnesses tied to vape and e-cigarette products. Healthcare professionals are still learning about the disease, and best practices for diagnosis, treatment, and terminology are still being determined. Read on to learn more about EVALI and e-cigarette or vaping product use-associated lung injury cases.
What does EVALI stand for?
EVALI is an acronym for E-cigarette or Vaping Product Use-Associated Lung Injury.
V: Vaping Product
What is E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI)?
E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI) is a dangerous, sometimes-fatal lung illness that began to sweep across the country in the latter half of 2019. The Centers for Disease Control and Prevention (CDC) first recognized EVALI in August of 2019 after healthcare professionals across the U.S. reported increased cases of patients with severe lung infections. Patients were hospitalized for symptoms such as shortness of breath, chest pain, and fever. As cases increased and more details emerged, researchers and doctors learned that all patients shared something in common: they all reported recently using vaping or e-cigarette products.